缺血性卒中静脉溶栓后有症状颅内出血：预测和治疗

Symptomatic intracranial hemorrhage after intravenous thrombolysis in ischemic stroke： prediction and treatment

阿替普酶静脉溶栓是目前急性缺血性卒中最有效的药物治疗方法.溶栓后出血性转化,尤其是有症状颅内出血（symptomatic intracranial hemorrhage,sICH）将严重影响静脉溶栓后转归,甚至威胁患者的生命.因此,静脉溶栓后sICH的预测和治疗显得尤为重要.文章就静脉溶栓后sICH的预测和治疗进行了综述.

 [Abstraet] Alteplase intravenous thrombolysis is the most effective drug treatment for acute ischemic stroke at present.Hemorrhagic transformation after thrombolysis,especially symptomatic intracranial hemorrhage （sICH）,will seriously affect the outcomes after intravenous thrombolysis,and even threaten the life of patients.Therefore,the prediction and treatment of sICH after intravenous thrombolysis is particularly important.This article reviews the prediction and treatment of sICH after intravenous thrombolysis.